As drug development increasingly targets multiple indications, pharma companies must make strategic branding ...

‘What The Fat?’, co-authored by Caryn Zinn, Craig Rodger, and Grant Schofield, highlights a low-carb, healthy-fat diet, and is held up as an effective weight loss tool. Dr Zinn joined Kerre Woodham ...

Ozempic has gained a lot of popularity with many referring to it as the miracle weight loss drug However how much do you ...

Three people share the hoops they've jumped through, financial strain they've endured and risks they've taken on in order to ...

Hims & Hers Health (HIMS -3.91%) is a telehealth company that offers personalized solutions for its customers. And demand has ...

The Dalai Lama said on Wednesday the institution of the Dalai Lama will continue and the Gaden Phodrang trust has sole ...

Biocon Ltd. plans to file for regulatory approvals of generic versions of Novo Nordisk A/S’s Ozempic and Wegovy in key ...

This change is happening because there’s another covered medication that’s safe and effective for your condition and may cost ...

Top executives ignored warnings that the company was not sufficiently prepared for the launch of its weight-loss drug Wegovy, leaving the drugmaker in a more vulnerable position when rival Eli Lilly ...

Both semaglutide and tirzepatide for type 2 diabetes and weight loss are GLP-1 agonists, meaning they mimic the hormone.

CVS Caremark will stop covering Eli Lilly's Zepbound, a weight loss drug, due to insurance company changes. Patients are outraged and concerned.